(0.09%) 5 521.75 points
(0.12%) 39 893 points
(0.20%) 19 790 points
(-0.01%) $81.62
(0.60%) $2.83
(-0.30%) $2 337.40
(0.14%) $29.57
(0.27%) $1 004.50
(0.02%) $0.932
(-0.05%) $10.53
(0.00%) $0.788
(-0.85%) $87.25
2 days till quarter result
(tns 2024-06-27)
Expected move: +/- 8.56%
1.29% $ 0.385
Live Chart Being Loaded With Signals
Aceragen, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare pulmonary and rheumatic diseases in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 52 509 |
Średni wolumen | 92 008 |
Kapitalizacja rynkowa | 3.24M |
EPS | $0 ( Q1 | 2023-03-31 ) |
Następna data zysków | ( $0 ) 2024-06-27 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0448 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.131 (34.47%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-05-17 | Pillar Invest Corp | Buy | 26 965 | Common Stock |
2023-07-12 | Pillar Invest Corp | Sell | 3 605 | Common Stock |
2023-07-13 | Pillar Invest Corp | Sell | 2 213 | Common Stock |
2023-05-16 | Pillar Invest Corp | Buy | 0 | Common Stock |
2023-05-16 | Pillar Invest Corp | Buy | 0 | Common Stock |
INSIDER POWER |
---|
59.87 |
Last 3 transactions |
Buy: 26 965 | Sell: 5 818 |
Wolumen Korelacja
Aceragen, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Aceragen, Inc. Korelacja - Waluta/Towar
Aceragen, Inc. Finanse
Annual | 2022 |
Przychody: | $4.86M |
Zysk brutto: | $4.86M (100.00 %) |
EPS: | $-7.17 |
FY | 2022 |
Przychody: | $4.86M |
Zysk brutto: | $4.86M (100.00 %) |
EPS: | $-7.17 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Aceragen, Inc.
Aceragen, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare pulmonary and rheumatic diseases in the United States. Its clinical development pipeline includes ACG-701, which is in Phase 2 clinical trial for cystic fibrosis pulmonary exacerbations, as well as for melioidosis; and ACG-801 for farber disease. Aceragen, Inc. has a collaboration and option agreement with Scriptr Global, Inc. to identify, research, and develop gene therapy candidates for the treatment, palliation, diagnosis, or prevention of myotonic dystrophy type 1 and Friedreich\'s Ataxia. The company was formerly known as Idera Pharmaceuticals, Inc. and changed its name to Aceragen, Inc. in January 2023. Aceragen, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej